Miami Valley Hospital to enroll COVID-19 patients for Regeneron antibody study

Miami Valley Hospital to enroll COVID-19 patients for Regeneron antibody study
Miami Valley Hospital announced Monday that they are the first hospital in the state to conduct inpatient and outpatient REGN-COV2 treatment for those diagnosed with COVID-19. (FOX19 NOW Photo/Mike Woeste)

DAYTON, Ohio (FOX19) - Miami Valley Hospital announced Monday that they are the first hospital in the state to start enrolling inpatients and outpatients diagnosed with COVID-19 for a study of Regeneron’s antibody treatment.

It is the same treatment that President Donald Trump received when he was diagnosed with the coronavirus.

“It consists of two potent, complementary virus-neutralizing antibodies and was designed specifically to target the SARS-CoV-2 (COVID-19) virus,” officials stated in a press release. “Preliminary data released by Regeneron showed that REGN-COV2 reduced viral levels and time to alleviate symptoms in non-hospitalized patients with COVID-19.”

Those who are interested in participating should complete an online screen test to see if they qualify.

Copyright 2020 WXIX. All rights reserved.